JPMorgan lowers Lennar stock price target to $92 on reduced delivery outlook

Lennar (LEN) reported Q3 earnings and revenue that missed analyst expectations, delivering 21,400 homes against a 22,000-23,000 unit guidance, and subsequently lowered its fiscal year 2025 delivery outlook to prioritize margins amid softening market conditions. Following this, JPMorgan reduced its price target to $92 from $97 and lowered EPS estimates, citing the updated guidance and "somewhat expensive" valuation, while Citizens JMP, conversely, raised its price target to $140, highlighting mixed analyst sentiment despite the operational adjustments and missed financial targets.

Analysis

Lennar Corporation (LEN) is actively managing a softening housing market by strategically shifting from volume growth to margin preservation, a move underscored by its recently revised fiscal year 2025 guidance. The company missed third-quarter expectations, with home deliveries of 21,400 falling short of its 22,000-23,000 unit guidance, and EPS of $2.00 missing the $2.10 consensus. Consequently, Lennar has materially lowered its full-year 2025 delivery forecast from over 86,000 units to a range of 81,200-82,200. This reduction is intended to establish a floor on margins, which slipped to 17.5% in Q3 (below the 18.0% guidance) as sales incentives rose 100 basis points to 14.3% of home values. This operational pivot has elicited divergent reactions from the analyst community. JPMorgan reiterated a Neutral rating and cut its price target to $92 from $97, citing the lowered guidance and a "somewhat expensive" valuation, while also reducing its FY25 and FY26 EPS estimates. In contrast, Citizens JMP raised its price target to $140 from $130, maintaining a Market Outperform rating despite the earnings miss. Despite these headwinds, Lennar's financial health is rated as "GOOD," supported by a strong balance sheet with a current ratio of 14.31 and a 48-year history of dividend payments.

Key Decisions for Investors

• Investors should weigh the company's defensive strengths, such as its strong balance sheet and dividend history, against the significant reduction in fiscal 2025 delivery guidance which signals near-term growth headwinds.
• Monitor future gross margin performance and the level of sales incentives closely, as these will be key indicators of whether the new strategy to sacrifice volume for margin stability is succeeding in a softening market.
• The wide divergence in analyst price targets, with JPMorgan at $92 and Citizens JMP at $140, suggests significant uncertainty and warrants a critical evaluation of whether the current stock price adequately reflects the revised, lower-growth operational outlook.